SAN FRANCISCO GENERAL HOSPITAL ADOPTS "SMART" ENLUXTRA SELF-ADAPTIVE WOUND DRESSING TO IMPROVE PATIENT OUTCOMES AND REDUCE WOUND CARE COSTS
SANTA CLARA, Calif., Jan. 21, 2015 -- San Francisco General Hospital and Trauma Center, San Francisco, CA, one of the nation's top hospitals, has adopted Enluxtra Self-Adaptive Wound Dressings for use, following a successful trial by hospital wound care clinicians.
San Francisco General Hospital (SFGH) is the latest top U.S. hospital among others using the Enluxtra dressing to improve patient outcomes and cut costs.
"We were pleased with the trial results achieved with chronic wound patients and feel the self-adaptive dressing can replace several other wound care products, reducing inventory costs while simplifying wound treatment procedures. That improves the efficiency of medical staff and greatly benefits our patients," stated Ossie Gabriel, RN, MSN, Wound CNS at SFGH.
Enluxtra is a "smart" multi-functional dressing developed for use on any wound in any healing stage. The dressing is designed to mitigate most of wound-related factors that can impede wound healing process, all at the same time. Enluxtra also efficiently supports major healing processes in the wound, such as superior drainage management, optimal moist microenvironment, autolytic debridement, granulation and re-epithelialization.
The unique dressing's ability to automatically self-adjust its function depending on the wound's needs combined with its superior absorbency allows Enluxtra to stay on continuously and unpredictably evolving wounds longer. With Enluxtra, clinicians are more confident in the dressing choice and expected healing outcomes throughout the whole cycle of wound healing.
For hospital clinicians, this simplifies the wound care process reducing errors and streamlining complicated protocols. The dressing's adaptive multi-functionality and versatility can eliminate dozens of single-function wound care products from hospital inventory and bring significant labor and material savings.
For patients, Enluxtra reduces the frequency and overall number of dressing changes, and minimizes pain because it doesn't adhere to the wound and effectively keeps wound moist.
"We are excited that SFGH, one of the nation's leading hospitals, has adopted use of our Self-Adaptive Dressing Technology and Enluxtra wound dressings. For SFGH and all other healthcare providers, Enluxtra means greater staff efficiency, the ability to serve more patients and achieve better healing results," stated Oleg Siniaguine, CEO of OSNovative Systems, Inc., the manufacturer of Enluxtra. "Enluxtra is the perfect dressing for saving great amounts in inventory costs, hundreds of hours of staff labor, and, most important, patients' limbs and lives."
About San Francisco General Hospital
San Francisco General Hospital and Trauma Center (SFGH) is an essential part of San Francisco's health care system serving some 100,000 patients each year and providing 20 percent of the city's inpatient care. Recognized as one of the nation's top hospitals, SFGH serves the community with a full complement of inpatient, outpatient, emergency, diagnostic and psychiatric services. SFGH and the University of California, San Francisco School of Medicine (UCSF) have been partners in public health since 1872, attracting physicians who are leaders in their fields and making SFGH one of the nation's top academic medical centers, and resulting in real time benefits to the patients by offering the best care that medical science has to offer.
About OSNovative Systems
OSNovative Systems, Inc. is a pioneer in self-adaptive wound care technology committed to developing, manufacturing and selling proprietary devices for advanced wound management, combat/emergency medicine and cosmetic skin care. This rapidly growing Silicon Valley-based start-up company is owned and managed by a team of dedicated professionals, who are passionate about bringing the most innovative wound care products to healthcare providers and patients.
Contact Information:
Polina D. Krasnova
Communications and PR Manager
OSNovative Systems, Inc.
Direct Line: 650-483-9938
Toll Free: 888-519-2297 ext. 417
Email: polinak@osnovative.com
###
San Francisco General Hospital (SFGH) is the latest top U.S. hospital among others using the Enluxtra dressing to improve patient outcomes and cut costs.
"We were pleased with the trial results achieved with chronic wound patients and feel the self-adaptive dressing can replace several other wound care products, reducing inventory costs while simplifying wound treatment procedures. That improves the efficiency of medical staff and greatly benefits our patients," stated Ossie Gabriel, RN, MSN, Wound CNS at SFGH.
Enluxtra is a "smart" multi-functional dressing developed for use on any wound in any healing stage. The dressing is designed to mitigate most of wound-related factors that can impede wound healing process, all at the same time. Enluxtra also efficiently supports major healing processes in the wound, such as superior drainage management, optimal moist microenvironment, autolytic debridement, granulation and re-epithelialization.
The unique dressing's ability to automatically self-adjust its function depending on the wound's needs combined with its superior absorbency allows Enluxtra to stay on continuously and unpredictably evolving wounds longer. With Enluxtra, clinicians are more confident in the dressing choice and expected healing outcomes throughout the whole cycle of wound healing.
For hospital clinicians, this simplifies the wound care process reducing errors and streamlining complicated protocols. The dressing's adaptive multi-functionality and versatility can eliminate dozens of single-function wound care products from hospital inventory and bring significant labor and material savings.
For patients, Enluxtra reduces the frequency and overall number of dressing changes, and minimizes pain because it doesn't adhere to the wound and effectively keeps wound moist.
"We are excited that SFGH, one of the nation's leading hospitals, has adopted use of our Self-Adaptive Dressing Technology and Enluxtra wound dressings. For SFGH and all other healthcare providers, Enluxtra means greater staff efficiency, the ability to serve more patients and achieve better healing results," stated Oleg Siniaguine, CEO of OSNovative Systems, Inc., the manufacturer of Enluxtra. "Enluxtra is the perfect dressing for saving great amounts in inventory costs, hundreds of hours of staff labor, and, most important, patients' limbs and lives."
About San Francisco General Hospital
San Francisco General Hospital and Trauma Center (SFGH) is an essential part of San Francisco's health care system serving some 100,000 patients each year and providing 20 percent of the city's inpatient care. Recognized as one of the nation's top hospitals, SFGH serves the community with a full complement of inpatient, outpatient, emergency, diagnostic and psychiatric services. SFGH and the University of California, San Francisco School of Medicine (UCSF) have been partners in public health since 1872, attracting physicians who are leaders in their fields and making SFGH one of the nation's top academic medical centers, and resulting in real time benefits to the patients by offering the best care that medical science has to offer.
About OSNovative Systems
OSNovative Systems, Inc. is a pioneer in self-adaptive wound care technology committed to developing, manufacturing and selling proprietary devices for advanced wound management, combat/emergency medicine and cosmetic skin care. This rapidly growing Silicon Valley-based start-up company is owned and managed by a team of dedicated professionals, who are passionate about bringing the most innovative wound care products to healthcare providers and patients.
Contact Information:
Polina D. Krasnova
Communications and PR Manager
OSNovative Systems, Inc.
Direct Line: 650-483-9938
Toll Free: 888-519-2297 ext. 417
Email: polinak@osnovative.com
###
